BioCentury

7:00 AM GMT, Jul 12, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Avastin bevacizumab regulatory update

The U.K.'s NICE issued an preliminary appraisal recommending against the use of Avastin bevacizumab from Roche in combination with a taxane for

Read the full 228 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.